At HIMSS15, EHR provider Practice Fusion and AstraZeneca today announced a Population Health Management (PHM) program that arms members of Practice Fusion’s community of 112,000 medical professionals with data-driven insights that can help them in their efforts to improve care for patients with asthma or chronic obstructive pulmonary disease (COPD).
The program, developed by Practice Fusion and sponsored by AstraZeneca, identifies patients whose current asthma or COPD care does not meet evidence-based clinical guidelines, and then alerts physicians at the point of care via patient charts within the EHR platform. The alerts are based on clinical guidelines from the National Heart, Lung, and Blood Institute and the Global Initiative for Chronic Obstructive Lung Disease.
As part of this program, practitioners will also have access to a dashboard within the Practice Fusion EHR platform, which includes real-time and aggregate views of their patients’ health. Through this dashboard, providers will be able to see the percentage of their patient populations with asthma and COPD, as well as the percentage of those patients whose care meets evidence-based clinical guidelines. Clinicians will be able to compare their patient populations’ percentages with the median percentages of similar patient populations across all other providers using the Practice Fusion EHR.
According to the Asthma and Allergy Foundation of America, nearly 25 million Americans suffer from asthma, which accounts for more than 3,300 deaths each year. A March 2013 report from the American Lung Association found that COPD is the third leading cause of death in the U.S and that more than 12 million adult Americans have been diagnosed with COPD.
For more information on PHM programs with Practice Fusion, please visithttp://www.practicefusion.com/pharma.